Liver Cell Type-Specific Targeting by Nanoformulations for Therapeutic Applications
Leonard Kaps(Johannes Gutenberg University Mainz), Matthias Bros(University Medical Center of the Johannes Gutenberg University Mainz)
Cited by 12
Related Papers
DNA Vaccines—How Far From Clinical Use?
|International Journal of Molecular Sciences|2018|451
Interleukin-1 Beta—A Friend or Foe in Malignancies?
|International Journal of Molecular Sciences|2018|431
The Wnt/β-Catenin Pathway Attenuates Experimental Allergic Airway Disease
|The Journal of Immunology|2014|49
Geldanamycin-mediated inhibition of heat shock protein 90 partially activates dendritic cells, but interferes with their full maturation, accompanied by impaired upregulation of RelB
|Journal of Experimental & Clinical Cancer Research|2014|12